Serial Number | 79026596 |
Word Mark | RIVOPHARM |
Filing Date | Tuesday, July 25, 2006 |
Status | 709 - CANCELLED - SECTION 71 |
Status Date | Friday, June 27, 2014 |
Registration Number | 3340188 |
Registration Date | Tuesday, November 20, 2007 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, September 4, 2007 |
Goods and Services | Pharmaceutical preparations, both prescription and over-the-counter, namely pharmaceutical preparations for peptic ulcer and gastroesophageal reflux disease (GORD), propulsives, intestinal anti-infectives, intestinal anti-inflammatory agents, oral pharmaceutical preparations for lowering blood glucose, Vitamin A and D, mixed vitamin preparations consisting of vitamins A and D, vitamin and mineral preparations for medical use, vitamin C in the nature of ascorbic acid, mixed vitamin preparations consisting partially of Vitamin C, calcium supplements, mineral supplements, anti-thrombotic agents, intravenous solutions, cardiac glycosides, class I and class III anti-arrhythmics, pharmaceutical preparations for cardiac stimulation excluding cardiac glycosides, Vasodilators used in the treatment of cardiac diseases, anti-adrenergic agents, pharmaceutical preparations for acting on arteriolar smooth muscle, Beta blocking agents, Selective calcium channel blockers, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors combined with other pharmaceutical preparations, anti-fungals for systemic use, anti-infectives and antiseptics, excluding those combined with corticosteroids, oxytocics, plain corticosteroids for systemic use, thyroid preparations, anti-thyroid preparations, tetracyclines preparations, macrolides, lincosamides and streptogramins, aminoglycoside antibacterials, quinolone antibacterials, antimycotics for systemic use, direct acting antivirals, immune sera, bacterial vaccines, alkylating agents, anti-metabolites, plant alkaloids, cytotoxic antibiotics, hormone antagonists and related agents, namely anti-estrogens, anti-androgens and enzyme inhibitors, immunosuppressive agents, anti-inflammatory and anti-rheumatic preparations, non-steroids in the nature of butylpyrazolidines, acetic acid derivatives, oxicams, propionic acid derivatives, fenamates, Coxibs, muscle relaxants, peripherally acting agents in the nature of curare alkaloids and choline derivatives, antigout preparations, analgesics and antipyretics preparations, anti-migraine preparations, anti-epileptic preparations, anti-cholinergic agents, dopaminergic agents, anti-psychotics, anxiolytics, hypnotics and sedatives, antidepressants, parasympathomimetics, agents for use against amoebiasis and other protozoal diseases, anti-malarial preparation, adrenergics, inhalant anesthetics, adrenergics for systemic use, antihistamines for systemic use, diuretic agents |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, June 27, 2014 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | RIVOPHARM S.A. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | CH-6928 Manno CH |
Party Name | RIVOPHARM S.A. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | CH-6928 Manno CH |
Party Name | RIVOPHARM S.A. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | CH-6928 Manno CH |
Event Date | Event Description |
Friday, November 3, 2017 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Friday, October 13, 2017 | NOTIFICATION PROCESSED BY IB |
Friday, December 9, 2016 | REFUSAL PROCESSED BY IB |
Friday, July 24, 2015 | TOTAL INVALIDATION PROCESSED BY THE IB |
Monday, July 6, 2015 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
Monday, July 6, 2015 | INVALIDATION PROCESSED |
Friday, February 27, 2015 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
Friday, June 27, 2014 | CANCELLED SECTION 71 |
Friday, June 5, 2009 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Wednesday, February 27, 2008 | FINAL DISPOSITION NOTICE SENT TO IB |
Wednesday, February 27, 2008 | FINAL DISPOSITION PROCESSED |
Wednesday, February 20, 2008 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, November 20, 2007 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, September 4, 2007 | PUBLISHED FOR OPPOSITION |
Wednesday, August 15, 2007 | NOTICE OF PUBLICATION |
Tuesday, May 29, 2007 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Tuesday, May 29, 2007 | ASSIGNED TO LIE |
Thursday, May 10, 2007 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, April 18, 2007 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, April 18, 2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, April 18, 2007 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, February 6, 2007 | NON-FINAL ACTION MAILED |
Monday, February 5, 2007 | NON-FINAL ACTION WRITTEN |
Monday, January 15, 2007 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, January 15, 2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, January 15, 2007 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, January 5, 2007 | REFUSAL PROCESSED BY IB |
Monday, December 18, 2006 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Monday, December 18, 2006 | REFUSAL PROCESSED BY MPU |
Thursday, December 14, 2006 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Wednesday, December 13, 2006 | NON-FINAL ACTION WRITTEN |
Wednesday, December 6, 2006 | ASSIGNED TO EXAMINER |
Friday, September 8, 2006 | NEW APPLICATION ENTERED IN TRAM |
Thursday, September 7, 2006 | SN ASSIGNED FOR SECT 66A APPL FROM IB |